To investigate whether DMF administration inhibited the hyperactivation of microglia and astrocytes, we measured the levels of Iba-1 and GFAP in the spinal cord of mice with STZ-induced diabetic neuropathy. Here, GFAP is linked to diabetic neuropathy.